Skip to main content

Doris and Alice on Big Pharma and Motorized Scooters

We had dinner with family friends Doris and Alice last night.  Doris is 90 and Alice is 91.  They have some strong opinions (they always do).  Doris and Alice gave permission for sharing their opinions on GeriPal, with their picture.
  • Big pharma is taking a hit, according to recent headlines.  Lots of drugs are going off patent and becoming generic.  Few new drugs are in the pipeline. Should we feel sorry for big pharma? Doris and Alice:  "No! We have enough drugs already."  The relentless profit incentive of big pharma drives up costs of drugs to levels that are bankrupting seniors and our economy. "They make too much money already." 
  • "Motorized scooters are a scam!"  Of course motorized scooters are a good thing for some folks who really can't walk.  But Doris and Alice find themselves bombarded with advertisements for motorized scooters.  They feel that the advertisements are disingenuous when they advertise themselves as "free" or "at no cost to you."  The cost is to our health care system, paid for by Medicare via our taxes, and these wheelchairs are never re-used.  Both are liberal politically - and still march in local rallies - but said "it makes me feel like a conservative republican to say this is fraud and abuse of our tax dollars." They also know of elders who have given up on physical therapy for the ease of getting around in a motorized scooter.  The ads imply that "anyone who wants one can have one - even if they're not disabled" They say, "intermediaries who sell these scooters are taking advantage of seniors." 
What do you think?

by: Alex Smith

Comments

Alex Smith said…
My mom who is 65 received a robo-call this morning saying, "if you or someone else in your home is on Medicare and using a cane or having mobility problems you may be eligible for a motorized scooter.". Too bad we don't have similar adds for physical therapy and walking. Outreach in and of itself isn't the problem. It's the profit that drives selected outreach of expensive devices that is problematic.
ken covinsky said…
The use and cost of motorized scooters are very difficult problems. I have always thought these devices are both vastly underused and overused.

On the one hand, their are a lot of patients who have very serious mobility problems who would get enourmous benefit. They refuse the soooter becasue they are afraid to acknowledge their mobilty problem, or because it is not offered to them. I have seen a number of patients have their life space mobilty restored with scooters.

On the other hand, the promotion and marketing of soooters is scandolous. The companies are very aggressive. The marketing is not based on doing good for patients but on extracting $$ from Medicare.

It is a shame Medicare is not allowed to negotiate for the best price on scooters. One wonders how much the price would fall if the soooter companies had to compete based on price and quality. Seems like a great opportunity to let free markets work.
Dan Matlock said…
Ken's points are well said - knowing who benefits from a scooter (in terms of increased mobility and a broader world) vs. who is harmed by a scooter (in terms of accelerated functional decline from losing the only exercise they were getting) is a vexing geriatric challenge.
Lynn O'Neill said…
I love that you had dinner with Doris and Alice. We all need a Doris and Alice in our lives with whom we can have intergenerational conversation away from our workplace!
Margo Smith said…
This from Doris and Alice themselves, reflecting on the original blog post during lunch today, 6/25/11.

Alice recalls the line from scooter commercials that scooters will be "paid in full," but wonders why each of these perfectly usable (and well compensated) devices must be discarded in favor of new sales when they are no longer needed by their owners. Is there no market for used ones?

Doris has noticed recently that scooter producers have lessened their advertising. She wonders whether these companies are embarrassed by attention to their suggestion that consumers can game the Medicare system.

Popular posts from this blog

Lost in Translation: Google’s Translation of Palliative Care to ‘Do-Nothing Care’

by: Cynthia X. Pan, MD, FACP, AGSF (@Cxpan5X)

My colleagues often ask me: “Why are Chinese patients so resistant to hospice and palliative care?” “Why are they so unrealistic?” “Don’t they understand that death is part of life?” “Is it true that with Chinese patients you cannot discuss advance directives?”

As a Chinese speaking geriatrician and palliative care physician practicing in Flushing, NY, I have cared for countless Chinese patients with serious illnesses or at end of life.  Invariably, when Chinese patients or families see me, they ask me if I speak Chinese. When I reply “I do” in Mandarin, the relief and instant trust I see on their faces make my day meaningful and worthwhile.

At my hospital, the patient population is about 30% Asian, with the majority of these being Chinese. Most of these patients require language interpretation.  It becomes an interesting challenge and opportunity, as we often need to discuss advance directives, goals of care, and end of life care options…

Elderhood: Podcast with Louise Aronson

In this week's podcast we talk with Louise Aronson MD, MFA, Professor of Geriatrics at UCSF about her new book Elderhood, available for purchase now for delivery on the release date June 11th.

We are one of the first to interview Louise, as she has interviews scheduled with other lesser media outlets to follow (CBS This Morning and Fresh Air with Terry...somebody).

This book is tremendously rich, covering a history of aging/geriatrics, Louise's own journey as a geriatrician facing burnout, aging and death of family of Louise's members, insightful stories of patients, and more.

We focus therefore on the 3 main things we think our listeners and readers will be interested in.

First - why the word "Elder" and "Elderhood" when JAGS/AGS and others recently decided that the preferred terminology was "older adult"?

Second - Robert Butler coined the term ageism in 1969 - where do we see ageism in contemporary writing/thinking?  We focus on Louise's…

Psychedelics: Podcast with Ira Byock

In this week's podcast, we talk with Dr. Ira Byock, a leading palliative care physician, author, and public advocate for improving care through the end of life.

Ira Byock wrote a provocative and compelling paper in the Journal of Pain and Symptom Management titled, "Taking Psychedelics Seriously."

In this podcast we challenge Ira Byock about the use of psychedelics for patients with serious and life-limiting illness.   Guest host Josh Biddle (UCSF Palliative care fellow) asks, "Should clinicians who prescribe psychedelics try them first to understand what their patient's are going through?" The answer is "yes" -- read or listen on for more!

While you're reading, I'll just go over and lick this toad.

-@AlexSmithMD





You can also find us on Youtube!



Listen to GeriPal Podcasts on:
iTunes Google Play MusicSoundcloudStitcher
Transcript
Eric: Welcome to the GeriPal Podcast. This is Eric Widera.

Alex: This is Alex Smith.

Eric: Alex, I spy someone in our …